Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Why Dynavax Stock Is Skyrocketing Today
01:15pm, Monday, 01'st Feb 2021
The biotech had lots of good news.
Why Dynavax Shares Are Rallying Today
09:19am, Monday, 01'st Feb 2021
Dynavax Technologies Corporation (NASDAQ: DVAX) shares are advancing solidly after the company and Clover Biopharma issued an update on their joint coronavirus vaccine program. What Happened: China-b
EMERYVILLE, Calif., Feb. 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced
Dynavax and CEPI Announce $99 Million in Funding for CpG 1018 Adjuvant Manufacturing to Support the Global COVID-19 Response
07:01am, Monday, 01'st Feb 2021
OSLO, Norway AND EMERYVILLE, Calif., Feb. 1, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines,
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate
01:00am, Monday, 01'st Feb 2021
Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax's CpG 1018 plus alum in the first half of 2021 with an inter
10 Short Squeeze Candidates Under $10
08:36am, Saturday, 30'th Jan 2021
The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's
2 Great Stocks Under $10 a Share
07:05am, Thursday, 28'th Jan 2021
One is making a COVID-19 vaccine; the other is a fintech.
Why Dynavax Stock Is Vaulting Higher Today
12:13pm, Thursday, 07'th Jan 2021
The company reported positive clinical results for its hepatitis B vaccine.
Dynavax to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
04:05pm, Wednesday, 06'th Jan 2021
EMERYVILLE, Calif., Jan. 6, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that R
Why Dynavax Stock Is Jumping Today
11:42am, Friday, 11'th Dec 2020
The company's hepatitis B vaccine received good news in Europe.
Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
03:00am, Friday, 04'th Dec 2020
CHENGDU, China.--(BUSINESS WIRE)--Clover Biopharmaceuticals, a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines and therapeutics for the world's
Dynavax to Present at the 3rd Annual Evercore Virtual ISI HealthCONx Conference
04:05pm, Tuesday, 17'th Nov 2020
EMERYVILLE, Calif., Nov. 17, 2020 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced
Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate
06:00am, Monday, 16'th Nov 2020
HYDERABAD, India and HOUSTON and EMERYVILLE, Calif., Nov. 16, 2020 /PRNewswire/ -- Biological E. Limited (BE), a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies Corporation (
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q3 2020 Results - Earnings Call Transcript
06:19pm, Thursday, 05'th Nov 2020
Dynavax Technologies Corporation (DVAX) CEO Ryan Spencer on Q3 2020 Results - Earnings Call Transcript
7 Penny Stocks to Watch in November
08:14am, Friday, 30'th Oct 2020
Penny stocks have become a popular investment alternative in 2020's volatile corona-economy. Here's a look at 7 penny stock to watch in November.
